Skip to main navigation Skip to search Skip to main content

Study Results from University of Pennsylvania Update Understanding of Carcinomas [Perioperative Nivolumab Versus Observation In Patients With Renal Cell Carcinoma Undergoing Nephrectomy (Prosper Ecog-acrin Ea8143): an Open-label, Randomised, ...]

Press/Media

PeriodSep 2 2024

Media coverage

1

Media coverage

  • TitleStudy Results from University of Pennsylvania Update Understanding of Carcinomas [Perioperative Nivolumab Versus Observation In Patients With Renal Cell Carcinoma Undergoing Nephrectomy (Prosper Ecog-acrin Ea8143): an Open-label, Randomised, ...]
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date09/2/24
    PersonsRobert G. Uzzo